| dc.creator | Rikos D., Marogianni C., Provatas A., Bourinaris T., Arnaoutoglou M., Stathis P., Patrinos G.P., Dardiotis E., Hadjigeorgiou G.M., Xiromerisiou G. | en |
| dc.date.accessioned | 2023-01-31T09:51:32Z | |
| dc.date.available | 2023-01-31T09:51:32Z | |
| dc.date.issued | 2020 | |
| dc.identifier | 10.5334/tohm.61 | |
| dc.identifier.issn | 21608288 | |
| dc.identifier.uri | http://hdl.handle.net/11615/78513 | |
| dc.description.abstract | Background: Several European studies examined the role of C9orf72 repeat expansion in patients with Huntington-disease like phenotypes (HD-L). The scope of our study is to investigate the expansion frequency in a Greek HD-L cohort and the meta-analysis of all published cases. This will be of use in genetic counseling of these cases. Methods: A cohort of 74 patients with HD-L and 67 healthy controls were screened for the C9orf72 expansion status. Case-controls comparison was assessed with the Pearson’s chi-square statistic for a 2 × 2 table. A systematic database search was conducted and seven studies, including the current study, were considered eligible for inclusion in a meta-analysis considering a total of 812 patients with HD phenocopies. Pooled mutation frequency was calculated using a Random Effects model or the Mantel-Haezsel fixed effects model, depending on the observed heterogeneity. Results: In our cohort, one patient was found to have a pathologic expansion of C9orf72, and none from the control group (chi-square: 0.91, p-value: 0.34). Pooled mutation frequency was found at 2% (CI: 1–3%) with low heterogeneity (I2:15%). Discussion: Based on this meta-analysis the recommendation for genetic testing for C9orf72 expansions is further solidified. © 2020 The Author(s). | en |
| dc.language.iso | en | en |
| dc.source | Tremor and Other Hyperkinetic Movements | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089323826&doi=10.5334%2ftohm.61&partnerID=40&md5=703fd74be0666f2b062c8729277a46c9 | |
| dc.subject | guanine nucleotide exchange C9orf72 | en |
| dc.subject | repetitive DNA | en |
| dc.subject | case control study | en |
| dc.subject | demyelinating disease | en |
| dc.subject | female | en |
| dc.subject | genetic screening | en |
| dc.subject | genetics | en |
| dc.subject | Greece | en |
| dc.subject | human | en |
| dc.subject | male | en |
| dc.subject | meta analysis | en |
| dc.subject | middle aged | en |
| dc.subject | C9orf72 Protein | en |
| dc.subject | Case-Control Studies | en |
| dc.subject | DNA Repeat Expansion | en |
| dc.subject | Female | en |
| dc.subject | Genetic Testing | en |
| dc.subject | Greece | en |
| dc.subject | Heredodegenerative Disorders, Nervous System | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Center for Digital Research and Scholarship | en |
| dc.title | Screening for the C9orf72 expansion in Greek huntington disease phenocopies and controls and meta-analysis of current data | en |
| dc.type | journalArticle | en |